ELV Elevance Health RESULTS: Q2, Q2 operating REV $49.800B, Q2 EPS $6.71, Q2 ADJ EPS $7.45 vs. EST $6.21, Q2 benefit expense ratio 89.7%, El
ELV Elevance Health RESULTS: Q2, Q2 operating REV $49.800B, Q2 EPS $6.71, Q2 ADJ EPS $7.45 vs. EST $6.21, Q2 benefit expense ratio 89.7%, Elevance Health Earnings Notes:, Outlook FY EPS $20.1, Outlook FY ADJ EPS $27 vs. EST $26.9, Declares Q3 2026 dividend of $1.72 per share
ELV Elevance Health RESULTS: Q2, Q2 operating REV $49.800B, Q2 EPS $6.71, Q2 ADJ EPS $7.45 vs.
EST $6.21, Q2 benefit expense ratio 89.7%, Elevance Health Earnings Notes:, Outlook FY EPS $20.1, Outlook FY ADJ EPS $27 vs.
EST $26.9, Declares Q3 2026 dividend of $1.72 per share